Quick answers
- What is Allzital?
- Allzital is a brand name of Butalbital and acetaminophen, a prescription medicine. The FDA NDC Directory lists 1 Allzital product in 1 strength and form.
- Who makes Allzital?
- Pharmobedient holds the FDA application for Allzital (ANDA203484, approved December 4, 2015).
- Is there a generic or store brand of Allzital?
- Yes. The FDA NDC Directory lists 2 other products with the same active ingredients, strength and form as a Allzital product, 2 of them generic. Ask your pharmacist whether one is right for you.
- Has Allzital been recalled?
- No recall linked to Allzital products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Allzital is
Each Allzital product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Butalbital and acetaminophen · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| acetaminophen 325 mg · butalbital 25 mg tablet (oral) | Allzital | 2 products, 2 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Butalbital and acetaminophen →
FDA approval
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| ANDA203484 | Pharmobedient | December 4, 2015 | 1 |
Companies that list Allzital
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Allzital products.
- Larken Laboratories, Inc.1 product
Recalls
No recall linked to Allzital products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.